Concepedia

Spencer Van Decar

SV

1

Publications

19

Citations

1

H-Index

2023

Active since

Affiliations

Orbis Health Solutions (United States)(Current)

Spencer Van Decar is an author at Orbis Health Solutions (United States).

Publications per year

2023–2023

1

Publications

1

Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis

Elizabeth Lee Carpenter, Spencer Van Decar, Alexandra M. Adams et al. · Journal for ImmunoTherapy of Cancer · 2023 · 19 citations · Full text

Rows per page

1–1 of 1